Yttrium

An element of the rare earth family of metals. It has the atomic symbol Y, atomic number 39, and atomic weight 88.91. In conjunction with other rare earths, yttrium is used as a phosphor in television receivers and is a component of the yttrium-aluminum garnet (YAG) lasers.

Networked: 503 relevant articles (42 outcomes, 76 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Salem, Riad: 19 articles (08/2015 - 02/2005)
2.	Lewandowski, Robert J: 11 articles (08/2015 - 08/2005)
3.	Gordon, Leo I: 8 articles (09/2007 - 02/2002)
4.	Carr, Brian I: 7 articles (08/2012 - 02/2005)
5.	Emmanouilides, Christos: 7 articles (09/2007 - 02/2002)
6.	Witzig, Thomas E: 6 articles (07/2013 - 02/2002)
7.	Schilder, Russell J: 6 articles (09/2007 - 01/2004)
8.	Prous, J R: 6 articles (09/2006 - 05/2004)
9.	Rabasseda, X: 6 articles (09/2006 - 05/2004)
10.	Omary, Reed A: 5 articles (03/2014 - 08/2005)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2015 - "The role of (18)F-FDG positron emission tomography in the follow-up of liver tumors treated with (90)Yttrium radioembolization." 03/01/2013 - "To propose a new method to estimate lung mean dose (LMD) using technetium-99m labeled macroaggregated albumin ((99m)Tc-MAA) single photon emission CT (SPECT)/CT for (90)Yttrium radioembolization of liver tumors and to compare the LMD estimated using SPECT/CT with clinical estimates of LMD using planar gamma scintigraphy (PS). " 10/21/2011 - "Bioactive glasses as potential radioisotope vectors for in situ cancer therapy: investigating the structural effects of yttrium." 07/01/2011 - "Trans-arterial (90)yttrium radioembolization for patients with unresectable tumors originating from the biliary tree." 06/01/2011 - "Gastric ulceration is a relatively uncommon but well-described complication of yttrium 90 (Y90) radioembolization therapy in the locoregional treatment of hepatic tumors. "
2.	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/01/2007 - "A 75-year-old man with relapsed follicular non-Hodgkin lymphoma confined to a solitary lung mass was treated with radioimmunotherapy (RIT) using yttrium 90-ibritumomab tiuxetan. " 04/01/2003 - "Comparative physical and pharmacologic characteristics of iodine-131 and yttrium-90: implications for radioimmunotherapy for patients with non-Hodgkin's lymphoma." 04/01/2006 - "Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma." 10/01/2004 - "Ongoing trials with yttrium 90-labeled ibritumomab tiuxetan in patients with non-Hodgkin's lymphoma." 09/01/2004 - "We report updated time-to-event variables of a phase III randomized study comparing yttrium 90-labeled ibritumomab with rituximab standard therapy in 143 rituximab-naive patients with relapsed or refractory low-grade, follicular, or transformed CD20+ non-Hodgkin's lymphoma (NHL). "
3.	Neoplasm Metastasis (Metastasis) 01/01/2015 - "Alternative therapeutic methods for isolated liver metastases include radioembolization with yttrium 90 (Y90) and transarterial chemoembolization (TACE). " 01/01/2014 - "The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review." 06/01/2010 - "Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastases." 09/10/1982 - "[Yttrium-90-therapy of bone metastases]." 07/01/2011 - "Yttrium microspheres have been used successfully to treat liver metastasis from DSRCT. "
4.	Cicatrix (Scar) 01/01/2014 - "The aim of this study was to investigate the efficacy of the sequential combined 585 nm PDL and the 1064 nm neodymium:yttrium-aluminium-garnet laser (PDL/Nd:YAG) in the treatment of surgical scars and to evaluate the short-term effects by in vivo confocal microscopy (RCM) and the long-term effects by clinical assessment of the scars. " 06/01/2006 - "Anterior stromal puncture with insulin needles or Neodymium : aluminium-yttrium-garnet may enhance the epithelial adhesion to the basement membrane by scar formation and success rates of up to 80% have been reported in the treatment of recalcitrant RCE. " 03/01/2013 - "Our aim was to assess the improvement of facial acne scars with Erbium-doped Yttrium Aluminium Garnet (Er:YAG) 2940 nm fractional laser resurfacing and its adverse effects in 25 patients at a tertiary care teaching hospital. " 03/01/2013 - "Efficacy and safety of erbium-doped yttrium aluminium garnet fractional resurfacing laser for treatment of facial acne scars." 04/01/2012 - "The aim of this study was to assess the efficacy and safety of ablative fractional yttrium-scandium-gallium-garnet (YSGG) laser in patients with residual haemangiomas or with scarring after their surgery. "
5.	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/01/2014 - "(90) Yttrium ((90) Y)-Ibritumomab-Tiuxetan combines the targeting advantage of a monoclonal antibody with the radiosensitivity of Follicular Lymphoma (FL). " 08/01/2014 - "Yttrium 90-ibritumomab tiuxetan (90Y-IT) radioimmunotherapy has proved to be effective in relapsed follicular lymphoma (FL). " 03/01/2014 - "Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. " 01/01/2007 - "Ibritumomab, an (90)Yttrium ((90)Y) labelled radioimmunoconjugate, is registered in Europe to treat follicular lymphomas. " 07/01/2006 - "90Y-ibritumomab tiuxetan is a monoclonal antibody directed against the CD20 antigen to which a radioactive isotope of yttrium is attached, used for treating follicular lymphomas (FL). "

Related Drugs and Biologics

1.	Neodymium
2.	Erbium
3.	Gallium
4.	Scandium
5.	ibritumomab tiuxetan (Zevalin)
6.	Chromium
7.	Holmium
8.	Sodium Hypochlorite (Clorox)
9.	Calcium Hydroxide
10.	Lutetium

Related Therapies and Procedures

1.	Solid-State Lasers
2.	Lasers (Laser)
3.	Radioimmunotherapy
4.	Microspheres (Microsphere)
5.	Light Coagulation